| Hidden Valley Center | |
| 422 23rd Street, Oak Hill, West Virginia 25901 | |
| (304) 465-1903 | |
| Name | Hidden Valley Center |
|---|---|
| Location | 422 23rd Street, Oak Hill, West Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 80 |
| Occupancy Rate | 85.88% |
| Medicare ID (CCN) | 515147 |
| Legal Business Name | 422 23rd Street Operations Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1023186186 |
| Organization Name | OAK HILL SNF OPERATIONS LLC |
| Doing Business As | HIDDEN VALLEY CENTER |
| Address | 422 23rd St, Oak Hill, WV 25901 |
| Phone Number | 304-465-1903 |
News Archive
A new statement issued today by the American Heart Association emphasizes the importance of taking a multidisciplinary approach to the management of cardiovascular disease during pregnancy and outlines heart care before, during and after pregnancy.
The U.S. Army has awarded University of Montana researcher Dave Poulsen a $1 million grant to further develop a drug that limits damage caused by traumatic brain injuries.
The Director-General of the World Health Organisation, Dr. Lee Jong-wook of South Korea, has died suddenly following surgery for a blood clot on the brain.
A Regenstrief Institute and Eskenazi Health study reports on an innovative program that trains and supervises volunteers who act as advocates for adults and seniors who are unable to make their own decisions due to conditions like Alzheimer's disease or coma, but have no family or friends to help them.
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announce that they have been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
› Verified 5 days ago
| NPI Number | 1720081615 |
| Organization Name | FAYETTE COMMUNITY HEALTH CARE |
| Doing Business As | HIDDEN VALLEY HEALTH CARE CENTER |
| Address | 422 23rd St, Oak Hill, WV 25901 |
| Phone Number | 304-465-1903 |
News Archive
A new statement issued today by the American Heart Association emphasizes the importance of taking a multidisciplinary approach to the management of cardiovascular disease during pregnancy and outlines heart care before, during and after pregnancy.
The U.S. Army has awarded University of Montana researcher Dave Poulsen a $1 million grant to further develop a drug that limits damage caused by traumatic brain injuries.
The Director-General of the World Health Organisation, Dr. Lee Jong-wook of South Korea, has died suddenly following surgery for a blood clot on the brain.
A Regenstrief Institute and Eskenazi Health study reports on an innovative program that trains and supervises volunteers who act as advocates for adults and seniors who are unable to make their own decisions due to conditions like Alzheimer's disease or coma, but have no family or friends to help them.
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announce that they have been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
› Verified 5 days ago
| NPI Number | 1821272139 |
| Organization Name | 422 23RD STREET OPERATIONS LLC |
| Doing Business As | HIDDEN VALLEY CENTER |
| Address | 422 23rd St, Oak Hill, WV 25901 |
| Phone Number | 304-465-1903 |
News Archive
A new statement issued today by the American Heart Association emphasizes the importance of taking a multidisciplinary approach to the management of cardiovascular disease during pregnancy and outlines heart care before, during and after pregnancy.
The U.S. Army has awarded University of Montana researcher Dave Poulsen a $1 million grant to further develop a drug that limits damage caused by traumatic brain injuries.
The Director-General of the World Health Organisation, Dr. Lee Jong-wook of South Korea, has died suddenly following surgery for a blood clot on the brain.
A Regenstrief Institute and Eskenazi Health study reports on an innovative program that trains and supervises volunteers who act as advocates for adults and seniors who are unable to make their own decisions due to conditions like Alzheimer's disease or coma, but have no family or friends to help them.
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announce that they have been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new statement issued today by the American Heart Association emphasizes the importance of taking a multidisciplinary approach to the management of cardiovascular disease during pregnancy and outlines heart care before, during and after pregnancy.
The U.S. Army has awarded University of Montana researcher Dave Poulsen a $1 million grant to further develop a drug that limits damage caused by traumatic brain injuries.
The Director-General of the World Health Organisation, Dr. Lee Jong-wook of South Korea, has died suddenly following surgery for a blood clot on the brain.
A Regenstrief Institute and Eskenazi Health study reports on an innovative program that trains and supervises volunteers who act as advocates for adults and seniors who are unable to make their own decisions due to conditions like Alzheimer's disease or coma, but have no family or friends to help them.
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announce that they have been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 22.08 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 13.18 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 48.48 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.62 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.55 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.51 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.62 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 1.81 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 90.94 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.14 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 27.45 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.69 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 1.31 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.7 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 76.73 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 93.33 | 82.93 |
News Archive
A new statement issued today by the American Heart Association emphasizes the importance of taking a multidisciplinary approach to the management of cardiovascular disease during pregnancy and outlines heart care before, during and after pregnancy.
The U.S. Army has awarded University of Montana researcher Dave Poulsen a $1 million grant to further develop a drug that limits damage caused by traumatic brain injuries.
The Director-General of the World Health Organisation, Dr. Lee Jong-wook of South Korea, has died suddenly following surgery for a blood clot on the brain.
A Regenstrief Institute and Eskenazi Health study reports on an innovative program that trains and supervises volunteers who act as advocates for adults and seniors who are unable to make their own decisions due to conditions like Alzheimer's disease or coma, but have no family or friends to help them.
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announce that they have been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
› Verified 5 days ago